Hongchang International Past Earnings Performance
Past criteria checks 0/6
Hongchang International's earnings have been declining at an average annual rate of -57.8%, while the Medical Equipment industry saw earnings growing at 11.3% annually.
Key information
-57.8%
Earnings growth rate
78.4%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | n/a |
| Return on equity | -0.9% |
| Net Margin | -14.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses BreakdownBeta
How Hongchang International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 3 | 0 | 1 | 0 |
| 30 Sep 23 | 0 | 0 | 0 | 0 |
| 31 Mar 23 | 0 | 0 | 0 | 0 |
| 31 Dec 22 | 0 | 0 | 0 | 0 |
Quality Earnings: HCIL is currently unprofitable.
Growing Profit Margin: HCIL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if HCIL's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare HCIL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HCIL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.9%).
Return on Equity
High ROE: HCIL has a negative Return on Equity (-0.94%), as it is currently unprofitable.